SMARCB1 and colorectal carcinoma: From the top eight genes, SMARCB1 and STK38L—which display plausible growth associated functions and to our knowledge have not been implicated in MSI CRC before—were selected for further validation in functional studies where the effect of the mutations on the localization, molecular interactions, and enzymatic activity of the proteins was investigated.